References
- Barnes J, Anderson LA, Phillipson JD (2001): St John's wort (Hypericum perforatum L.): A review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53: 583–600.
- Bombardelli E, Morazzoni P (1995): Hypericum perforatum. Fitoterapia LXVI: 43–98.
- Brolis M, Gabetta N, Fuzzati R, Pace R, Panzeri F, Peterlongo F (1998): Identification by high-performance liquid-chromatography-UV absorbance detection of active con-stituents of Hypericum perforatum. J Chromatogr 825: 9–16.
- Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Muller WE (1998a): Hyperforin as a possible antidepres-sant component of hypericum extracts. Life Sci 63: 499–510.
- Chatterjee SS, Noldner M, Koch E, Erdelmeier C (1998b): Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 3/(Suppl): 7–15.
- Council of Europe (2000): Natural Sources of Flavourings. Report No. 1 Strasbourg: Council of Europe.
- Deutscher Arzneimittel Codex (DAC) (1986): (Ergänzung zum Arzneibuch), Govi Verlag, Frankfurt/Main (in der Ergänzung von 1991).
- Erdelmeier CAJ (1998): Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perfora-tor') L. Pharmacopsychiatry 3/(Suppl): 2–6.
- Hudson JB, Lopez-Bazzocchi I, Towers GNH (1991): Antiviral activity of hypericin. Antiviral Res 15: 101–112.
- Judd WS, Campbell CS, Kellogg EA, Stevens PF (1999): Plant Systematics — A Phylogenetic Approach, Sinauer Assoc., Inc. USA.
- Kitanov GM (2001): Hypericin and pseudohypericin in some Hypericum species. Biochem Syst Ecol 29: 171–178.
- Knox JP, Dodge AD (1985): Isolation and activity of the photo-dynamic pigment hypericin. Plant Cell Environ 8: 19–25.
- Kurth E, Spreemann R (1998): Phytochemical characterization of various St. John's Wort extracts. Adv Ther 15: 117–128.
- Laakmann G, Schille C, Baghai T, Keiser M (1998): St John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31(Suppl): 54–59.
- Lavie G, Mazur Y, Lavie D, Meruelo D (1995): The chemical and biological properties of hypericin-A compound with a broad spectrum of biological activities. Med Res Rev 15: 111–119.
- Liu FF, Ang CYW, Heinze TM, Rankin JD, Heger RD, Freeman JP, Jackson OL Jr (2000a): Evaluation of major active com-ponents in St. John's wort dietary supplements by high-performance liquid chromatography with photodiode array detection and electrospray mass spectrometric confirma-tion. J Chromatogr 888: 85–92.
- Liu FF, Ang CYW, Springer D (2000b): Optimization of extrac-tion conditions for active components in Hypericum perfo-ratum using response surface methodology. J Agric Food Chem 48: 3364–3371.
- Mártonfi P, Gabetta N, Miroslav R, Ciccarelli D, Garbari F (2001): Hypericum perforatum L. — chemotype without rutin from Italy. Biochem Syst Ecol 29: 659–661.
- Nahrstedt A, Butterweck V (1997): Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 30(Suppl): 129–134.
- Orth HCJ, Rentel C, Schmidt PC (1999): Isolation, purity analy-sis and stability of hyperforin as a standard material from Hypericum perforatum L. J Pharm Pharmacol 51: 193–200.
- Reichling J, Weseler A, Saller RA (2001): A current review of the antimicrobial activity of Hypericum perforatum L. Pharmacopsychiatry 34(Suppl): 116–118.
- Southwell IA, Campbell MH (1991): Hypericin content varia-tion in Hypericum perforatum in Australia. Phytochemistry 30: 475–478.
- Verotta L, Appendino G, Jakupovic J, Bombardelli E (2000): Hyperforin analogues from St. John's wort (Hypericum per-foratum). J Nat Prod 63: 412–415.